Bio-Matrix Scientific Group, Inc. (OTC: BMSN) Sky
Post# of 5066
Posted On: 07/28/2013 1:58:26 AM
Bio-Matrix Scientific Group, Inc. (OTC: BMSN) Sky High Penny Stock!
BMSN on Fire!
After dropping down significantly in recent days BMSN exhibited what it has been known for, Ability to REBOUND and show STRENGTH , by making a big bounce off $0.0027!
Anyone with an eye on Penny Stocks in recent weeks has seen the spectacular rise of Bio-Matrix Scientific Group, Inc. (OTC: BMSN) . Many investors are speculating this one goes way higher from current levels.
HemaXellerate I™ BMSN’s stem cell drug to combat Aplastic Anemia is eligible for Orphan Drug Status which makes HemaXellerate I™ able to get full FDA approval in as little as 60 days to bypass the lengthy Phase I, II, III, IV FDA Approval Processes because of being eligible for Orphan Drug Status.Penny Stock Speculators should be warned however that stories as juicy as this one do come around quite often on the sub-exchanges. Conclusion: BMSN has made an explosive move up as investors wait on news from the Food and Drug Administration (FDA) While HemaXellerate I™ could mean huge gains for investors.
BMSN on Fire!
After dropping down significantly in recent days BMSN exhibited what it has been known for, Ability to REBOUND and show STRENGTH , by making a big bounce off $0.0027!
Anyone with an eye on Penny Stocks in recent weeks has seen the spectacular rise of Bio-Matrix Scientific Group, Inc. (OTC: BMSN) . Many investors are speculating this one goes way higher from current levels.
HemaXellerate I™ BMSN’s stem cell drug to combat Aplastic Anemia is eligible for Orphan Drug Status which makes HemaXellerate I™ able to get full FDA approval in as little as 60 days to bypass the lengthy Phase I, II, III, IV FDA Approval Processes because of being eligible for Orphan Drug Status.Penny Stock Speculators should be warned however that stories as juicy as this one do come around quite often on the sub-exchanges. Conclusion: BMSN has made an explosive move up as investors wait on news from the Food and Drug Administration (FDA) While HemaXellerate I™ could mean huge gains for investors.
(0)
(0)